Open AccessOffsetting Impact of Thrombosis and Restenosis on the Occurrence of Death and Myocardial Infarction After Paclitaxel-Eluting and Bare Metal Stent Implantation
Author(s) -
Gregg W. Stone,
Stephen G. Ellis,
Antonio Colombo,
Keith D. Dawkins,
Eberhard Grube,
Donald E. Cutlip,
Mark I. Friedman,
Donald S. Baim,
Joerg Koglin
Publication year - 2007
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.106.687186
Subject(s) - medicine , myocardial infarction , paclitaxel , restenosis , cardiology , thrombosis , stent , bare metal stent , bare metal , coronary restenosis , drug eluting stent , chemotherapy
Drug-eluting stents compared with bare metal stents (BMS) may increase late stent thrombosis (ST), although an accompanying increase in the rates of death and myocardial infarction (MI) has not been observed. We hypothesized that the prevention of restenosis-related adverse events by drug-eluting stents might offset some or all of the excess risk from ST.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom